MARÍA INMACULADA
JIMÉNEZ NACHER
Researcher to 2024
National Institute of Allergy and Infectious Diseases
Bethesda, Estados UnidosPublications in collaboration with researchers from National Institute of Allergy and Infectious Diseases (1)
2011
-
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial
The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283